|
|
|
|
LEADER |
00782nam a2200241Ia 4500 |
001 |
10.1093-eurheartj-ehac090 |
008 |
220510s2022 CNT 000 0 und d |
020 |
|
|
|a 15229645 (ISSN)
|
245 |
1 |
0 |
|a In vivo generated chimeric antigen receptor T cells reduce fibrosis and restore cardiac function in experimental heart failure
|
260 |
|
0 |
|b NLM (Medline)
|c 2022
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1093/eurheartj/ehac090
|
650 |
0 |
4 |
|a fibrosis
|
650 |
0 |
4 |
|a Fibrosis
|
650 |
0 |
4 |
|a heart failure
|
650 |
0 |
4 |
|a Heart Failure
|
650 |
0 |
4 |
|a human
|
650 |
0 |
4 |
|a Humans
|
650 |
0 |
4 |
|a Receptors, Chimeric Antigen
|
650 |
0 |
4 |
|a T lymphocyte
|
650 |
0 |
4 |
|a T-Lymphocytes
|
700 |
1 |
|
|a Liuzzo, G.
|e author
|
700 |
1 |
|
|a Patrono, C.
|e author
|
773 |
|
|
|t European heart journal
|